PMMI research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome ...

HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

Plants are quietly borrowing tricks from bacteria, repurposing foreign genes to build complex molecules that look a lot like ...

Fierce’s Rebecca Willumson sat down with Swoop President Scott Rines – live at Digital Pharma East – to discuss some of the most pressing issues in pharma marketing today. Rines kicks off by debunking ...

Silicon Valley and Wall Street are pouring billions into AI drug discovery in a high-stakes bet to “solve” disease.

Traws Pharma, Inc. (TRAW) has disclosed a new risk, in the Corporate Activity and Growth category. The integration of Onconova and Trawsfynydd poses a significant risk to Traws Pharma, Inc.’s future ...

My initial rating of Abbott Laboratories is a buy, agreeing with today's Wall Street consensus. The future growth indicators, diversified portfolio across many clinical segments, and leading roles in ...

Pharmaceuticals used in health care provide huge health and economic benefits to society, but are now found extensively as ...

Lumos Pharma (NASDAQ:LUMO) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table provides a quick overview of ...

Medical patients can thought of as benchwarmers – closer even to spectators – in the healthcare game, watching pharmaceutical companies, large physician practice groups, and insurance companies call ...